BioLine Rx Ltd (BLRX)
0.3232
-0.22
(-40.71%)
USD |
NASDAQ |
Nov 21, 16:00
0.325
0.00 (0.00%)
Pre-Market: 08:37
BioLine Rx Gross Profit Margin (Quarterly): 83.37% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 83.37% |
| March 31, 2024 | 78.77% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
78.77%
Minimum
Mar 2024
83.37%
Maximum
Jun 2024
81.07%
Average
81.07%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Compugen Ltd | 78.98% |
| Pluri Inc | 61.35% |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -202.3% |
| Return on Assets | -51.59% |
| Return on Invested Capital | -102.9% |
| Profit Margin (Quarterly) | 8.97% |
| Operating Margin (Quarterly) | -107.0% |
| Return on Net Operating Assets | -120.4% |